AbbVie Inc., Cynosure LLC (A subsidiary of Hologic Inc.) and Cutera are Dominating the Europe Liposuction Devices Market in 2019

Europe Liposuction Devices Market is expected to grow with the CAGR of 9.8% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-liposuction-devices-market

Europe liposuction devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in the Europe liposuction devices market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in April 2019, Alma Lasers launched its new product named BeautiFill, the first laser-assisted fat harvesting platform in its surgical instruments categories. This new product launched by the company has increased its product portfolio leading to increased demand and sales for its product in future.

AbbVie Inc. is the dominating player in the Europe liposuction devices market. The other key players existing in the market includes AbbVie Inc., Alma Lasers (A subsidiary of Sisram Medical Ltd), Cynosure LLC (A subsidiary of Hologic Inc.), Cutera, Eurosurgical Ltd., NOUVAG AG, Human Med AG, BLINK MEDICAL, Energist Ltd., Murray Surgical, INTERmedic Arfran, CANDELA CORPORATION, Lipogems International S.p.A., Innovia Medical and Genesis Biosystems, Inc., Solta Medical (A subsidiary of Bausch Health Companies Inc.), BTL Group of Companies and El.En. S.p.A.

Europe Liposuction Devices MarketAbbVie Inc.

AbbVie Inc. was founded in 2013 and is headquartered in Illinois, U.S. The company is a research- driven biopharmaceutical company having a great focus on treating diseases in order to make a remarkable impact on people's lives. The company is providing segments under the US specialized therapeutics, U.S. general medicine, international and other among which US specialized therapeutics is the market focussed segment. The company providing products are central nervous system, eye care, gastroenterology, medical aesthetics and medical aesthetics is the market focus product category. The company is engaged in taking strategic initiatives to expand its portfolio of liposuction devices.

  • In May 2020, Abbvie Inc, completely acquired Allergan which merges the product portfolio of the two companies. This acquisition helped Abbvie Inc. to increase its market and demand of its product in future.

The company has wide its presence across Asia-Pacific, Europe, Middle East and Africa, North America and South America. The company has various subsidiaries like AbbVie Holdings Inc. (U.S.), AbbVie Pty Ltd (Australia), AbbVie SA (Belgium), AbbVie Farmacêutica Ltda. (Brazil) and AbbVie Productos Farmacéuticos Limitada (Chile) among more.

Cynosure LLC (A subsidiary of Hologic Inc.)

Cynosure LLC (A subsidiary of Hologic Inc.) is headquartered in Massachusetts, U.S. The company is engaged in creating energy-based aesthetic and medical treatment systems and offers a wide range of products for hair removal, scar reduction, skin revitalization, body contouring, gynecological health, and more. The company is providing products under for providers and for patients. The market focus products lie under for providers product category. The company is engaged in continuous development of liposuction devices.

  • In October 2019, Cynosure LLC (A subsidiary of Hologic Inc.) launched StimSure, a non-invasive technology using electromagnetic radiations in order to tone and build the muscles of regions like abdomen, buttocks and thighs, in Europe and the Middle East market. This new product launched by the company has increased its product portfolio in the market leading to increased revenue in future.

The company has wide presence across Europe and North America. The company also has various subsidiary companies such as Cynosure France (France), Cynosure K.K. (Japan), Cynosure GmbH (Germany), Cynosure Korea Limited (Korea) and Suzhou Cynosure Medical Devices Company Ltd. (China) among more.

Cutera:

Cutera was founded in 1998 and is headquartered in California, U.S. The company focuses on the manufacturing and development of medical aesthetic solutions. The company is engaged in providing products in truSculpt flex, excel V+, excel V, enlighten, excel HR, Juliet, Secret RF, truSculpt iD, truSculpt 3D and xeo among which truSculpt flex, truSculpt iD and truSculpt 3D is the market focused category.

  • In June, Cutera launched its new product named truSculpt flex for the muscle-sculpting market. This new product launched by the company increases its product portfolio in the medical aesthetic segment leading to increased demand for its product in the market.

The company has wide presence across Europe, North America, and Asia-Pacific. The company has various subsidiary companies such as CUTERA Pty. Limited (Australia), CUTERA SPRL (Belgium), CUTERA GmbH (Germany), CUTERA Medical Ltd. (UK) and CUTERA France (France) among more. The company has initiated many product launches to expand its market.